Log in to search using one of your social media accounts:


Gamida Cell launches severe aplastic anemia trial

Gamida Cell said today that the first patient has been transplanted in a study of its CordIn product for patients with severe aplastic anemia or hypoplastic myelodysplastic syndrome. The product is designed for patients with rare genetic diseases who have no fully-matched donors for a bone marrow transplantation. Gamida Cell said it is also evaluating its CordIn therapy for patients with sickle cell disease. Get the full story at our sister site, Drug Delivery Business News.   The post Gamida Cell launches severe aplastic anemia trial appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Research & Development Stem Cells Gamida Cell Source Type: news

Related Links:

More News: Anemia | Aplastic Anemia | Bone Marrow Transplant | Clinical Trials | Genetics | Myelodysplastic Syndrome | Sickle Cell Anemia | Stem Cell Therapy | Stem Cells | Study | Transplants